Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Blood|March 10, 2022
Exosomes in multiple myeloma: from bench to bedsideEline Menu, Karin Vanderkerken
Oncotarget|February 20, 2016
Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?Mérédis Favreau, Karin Vanderkerken, Dirk Elewaut, et al.
Archives of Physiology and Biochemistry|February 24, 2009
The role of the insulin-like growth factor 1 receptor axis in multiple myelomaEline Menu, Els van Valckenborgh, Ben van Camp, et al.
Disease Models & Mechanisms|November 2, 2012
Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse modelsJinsong Hu, Els Van Valckenborgh, Eline Menu, et al.
Molecular Immunology|August 29, 2018
Checkpoint inhibition in the treatment of multiple myeloma: A way to boost innate-like T cell anti-tumor function?Koen Venken, Mérédis Favreau, Djoere Gaublomme, et al.
Bulletin Du Cancer|April 9, 2008
Unraveling the biology of multiple myeloma disease: cancer stem cells, acquired intracellular changes and interactions with the surrounding micro-environmentJo Caers, Els Van Valckenborgh, Eline Menu, et al.
Oncotarget|December 24, 2015
Novel strategies to target the ubiquitin proteasome system in multiple myelomaSusanne Lub, Ken Maes, Eline Menu, et al.
Annals of the New York Academy of Sciences|December 18, 2002
The F-actin content of multiple myeloma cells as a measure of their migrationEline Menu, Filip Braet, Maarten Timmers, et al.
Advances in Cancer Research|June 28, 2011
The microenvironment and molecular biology of the multiple myeloma tumorMiguel Lemaire, Sarah Deleu, Elke De Bruyne, et al.
Cell Communication and Signaling : CCS|June 11, 2024
Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapyYanmeng Wang, Niels Vandewalle, Kim De Veirman, et al.
Pageof 17